RISK FACTOR MODIFICATION AFTER MYOCARDIAL-INFARCTION

被引:54
作者
SIEGEL, D
GRADY, D
BROWNER, WS
HULLEY, SB
机构
[1] UNIV CALIF SAN FRANCISCO, SAN FRANCISCO, CA 94143 USA
[2] VET ADM MED CTR, SAN FRANCISCO, CA 94121 USA
关键词
D O I
10.7326/0003-4819-109-3-213
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:213 / 218
页数:6
相关论文
共 86 条
[1]  
[Anonymous], 1965, LANCET, V2, P501
[2]  
[Anonymous], 1982, Lancet, V2, P1173
[3]  
[Anonymous], 1968, LANCET, V2, P693
[4]  
[Anonymous], 1984, ARCH INTERN MED, V144, P1045
[5]  
[Anonymous], 1978, J Chronic Dis, V31, P201
[6]   BENEFICIAL-EFFECTS OF COMBINED COLESTIPOL-NIACIN THERAPY ON CORONARY ATHEROSCLEROSIS AND CORONARY VENOUS BYPASS GRAFTS [J].
BLANKENHORN, DH ;
NESSIM, SA ;
JOHNSON, RL ;
SANMARCO, ME ;
AZEN, SP ;
CASHINHEMPHILL, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (23) :3233-3240
[7]  
BROWNER WS, 1988, IN PRESS HYPERTENSIO
[8]   15 YEAR MORTALITY IN CORONARY DRUG PROJECT PATIENTS - LONG-TERM BENEFIT WITH NIACIN [J].
CANNER, PL ;
BERGE, KG ;
WENGER, NK ;
STAMLER, J ;
FRIEDMAN, L ;
PRINEAS, RJ ;
FRIEDEWALD, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (06) :1245-1255
[9]  
CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36
[10]   MANAGEMENT OF PATIENTS AFTER MYOCARDIAL-INFARCTION [J].
COHEN, LS .
HOSPITAL PRACTICE, 1987, 22 (04) :149-&